Health X Platform Ltd (HEALTHX) — shareholding pattern, promoter holding, financials and share price
About Health X Platform Ltd (HEALTHX)
Health X Platform Ltd operates in the Healthcare Service Provider industry, within the Healthcare sector. It trades on the NSE as HEALTHX and on the BSE under scrip code 533259. Its ISIN is INE019J01013.
Incorporated in 1989, Sastasundar Ventures Ltd is in the business of digital network of healthcare and portfolio management services [1]
SastaSundar Ventures Limited (proposed Health X Platform Limited) operates an integrated digital healthcare platform combining pharmaceutical distribution (Retailer Shakti), a B2C pharmacy and wellness app (SastaSundar), diagnostics enablement, and franchise-led last-mile delivery via HealthBuddy. The company holds controlling interest in SastaSundar HealthBuddy Limited and aggregates digital enablement, automated fulfilment centres and retailer SaaS to serve consumers and 62,000+ pharmacies nationwide.
In Q3 FY26 SastaSundar reported consolidated healthcare operations revenue of ₹341.3 crore (total revenue ₹359.4 crore), up 22% year-on-year, with gross profit rising 55% and a gross margin of 7.6%; EBITDA loss narrowed to ₹14.8 crore and nine‑month PAT turned positive at ₹11.5 crore, driven materially by higher other income and operating efficiency improvements in procurement and fulfilment automation.
Listed peers in Healthcare Service Provider: Krsnaa Diagnostics Ltd, Suraksha Diagnostic Ltd, One Global Service Provider Ltd, 3B Blackbio DX Ltd, Gaudium IVF and Women Health Ltd, Chandan Healthcare Ltd.
Valuation & Returns
10 Jul 2026At ₹324 a share on 10 Jul 2026, Health X Platform Ltd (HEALTHX) was valued at a price-to-earnings ratio of 535x against an industry P/E of 61.73x and a price-to-book of 1.54x on a book value of ₹210.58 per share as of Mar 2025. Solomo computes return on equity of -0.22% and return on capital employed of -0.07% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 535x
- Industry P/E
- 61.73x
- P/B
- 1.54x
- EPS (TTM)
- ₹-0.46
- Book value / share
- ₹210.58
- ROE
- -0.22%
- ROCE
- -0.07%
- ROA
- -0.15%
- Debt / equity
- 0x
- Dividend yield
- 0%
- EBITDA margin
- 0.38%
- 52-week range
- ₹252.5 – ₹375
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Health X Platform Ltd (HEALTHX) reported revenue of ₹1,319 crore, net profit of ₹-1 crore and earnings per share of ₹0.37. That compares with revenue of ₹1,159 crore and net profit of ₹-134 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹374 crore and net profit ₹-13 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 1,798 | 1,060 | 1,432 | 1,159 | 1,319 |
| Net profit (₹ cr) | 865 | -99 | 6 | -134 | -1 |
| EPS (₹) | 197.05 | -22.7 | 2.79 | -28.66 | 0.37 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | -16.48% | 110.82% | - | -19.09% |
| Stock price CAGR | 16% | 0% | 5% | 12% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 74.07% of Health X Platform Ltd (HEALTHX) (down 0.77 pp QoQ), foreign institutional investors (FII) hold 2.29% and domestic institutional investors (DII) hold 2.6%. Market capitalisation was ₹1,031 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Dec 2010.
Largest disclosed public shareholders in Jun 2026: Lekh Raj Juneja 1.89%, LLP 1.57%, Magnum Health And Safety Pvt Ltd 1.44%, Sanjay Agarwal, Rahul Kumar Agrawal and Pratap Singh as Trustees of Microsec Vision Employees Trust 1.28%, Airavat Capital Trust - Airavat Capital Trust II 1.23%, Legends Global Opportunities (Singapore) Pte. Ltd. 1.15%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 74.07% | - | 2.29% | 2.6% | 25.93% |
| Mar 2026 | 74.84% | - | 2.17% | 2.6% | 25.16% |
| Dec 2025 | 74.69% | - | 2.25% | 2.07% | 25.31% |
| Sep 2025 | 74.24% | - | 2.04% | 2.07% | 25.76% |
| Jun 2025 | 74.24% | - | 1.88% | 2.09% | 25.76% |
| Mar 2025 | 74.11% | - | 1.6% | 2.06% | 25.89% |
| Dec 2024 | 73.94% | - | 1.71% | 1.85% | 26.06% |
| Sep 2024 | 73.92% | - | 0.99% | 1.98% | 26.08% |